Clinical Trials Logo

Cervical Cancer Metastatic clinical trials

View clinical trials related to Cervical Cancer Metastatic.

Filter by:
  • None
  • Page 1

NCT ID: NCT03912402 Recruiting - Cervical Cancer Clinical Trials

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)

Start date: December 25, 2018
Phase: Phase 2
Study type: Interventional

This is a multicenter, open-label, single-arm study of efficacy, safety and pharmacokinetics of BCD-100 (JSC BIOCAD, Russia) in combination with platinum-based chemotherapy and bevacizumab as first-line treatment in patients with recurrent/persistent or metastatic cervical cancer.

NCT ID: NCT03614949 Recruiting - Cervical Cancer Clinical Trials

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Start date: January 29, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to see if treatment with atezolizumab and stereotactic body radiation therapy (SBRT) will improve the objective response rate (ORR) compared with atezolizumab alone in patients with recurrent, persistent, or metastatic cervical cancer.